ArticleCell chemical biology2024
Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancer.
Tinslee Dilday et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it